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()f all the antigenic material used in immunological studies perhaps none has been 
as widely used in recent years as has the sheep erythrocyte. It has been the sheep red 
blood cell (SRBC) which has served so frequently as an indicator of serum agglutinins 
and hemolysins, as a means of quantitation of antibody-forming  cells by rosette forma- 
tion or by plaque assay, for delineation of both  19S and 7S antibody-secreting cells, 
for  induction of immune responses in vitro in organ culture and in cell suspension 
systems, for studies of maturation of immune competence, and for the basic work  in- 
volving cell collaboration in immunity. 
Unresponsiveness to  SRBC  can  be  induced both  in neonatal  (1)  and  adult  (2) 
animals by a  prolonged injection schedule with massive doses  of  SRBC.  More gen- 
erally, unresponsiveness has been induced by treatment with antigen in combination 
with cytotoxic agents such as cyclophosphamide (3-8). Neither method of induction of 
tolerance seems  entirely desirable, however.  Multiple injections of  SRBC  activate 
antibody synthesis and set into motion complex antibody-mediated feedback systems, 
while  drug-induced tolerance involves both  specific killing of antigen-sensitive cells 
as well as a general depressive effect on the general lymphocyte population. 
It  was  our  hope  to  obtain tolerance to  SRBC  in a  manner which  did not 
knowingly, involve ceil destruction, and which did not knowingly- involve activa- 
tion  of  typical  antibody formation against  SRBC.  We  felt  that  if  we  could 
obtain tolerance in such a manner we might more closely- approximate the type 
of  tolerance significant in the  normal development of  immunity versus  unre- 
sponsiveness. In analogy- to studies with protein antigens (e.g.  aggregated vs. 
disaggregated forms of human gamma globulin; cf. references 9 and 10 for re- 
view) a number of investigators have attempted to use solubilized SRBC com- 
ponents for induction of tolerance (11  13). However, in these studies the tolero- 
genie material was initially antigenic and could therefore be assumed to induce 
tolerance in the same manner as massive doses of intact SRBC. The experiments 
which we present involve simple saline extraction of hemolvzed SRBC followed 
by" centrifugation to obtain a membrane-free preparation. Our material appears 
to be nonantigenic, yet significantly reduces the subsequent specific response to 
SRBC. 
* Supported in part by grant GB 6637X from the National Science Foundation. 
The  initial phases of  this stud), were presented as a  Master's  Degree dissertation  of 
T.H.A. at the University of Wisconsin. 
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Materials and Methods 
Animals.--Inbred BALB/CAu  mice from our  laboratory  and  additional  BALB/CJax 
animals purchased from Jackson Laboratory,  Bar  Harbor,  Maine, were used in our initial 
studies.  Subsequently,  BDFI  mice (C57/BL6  X  DBA/2)  obtained  from ARS-Sprague 
Dawley were used with equivalent results. Experiments were carried out on 2-3-months old 
male mice. 
Erythrocytes.--SRBC and horse red blood cells (HRBC) were obtained from specific donor 
animals as a 50c~c suspension in Alsever's solution. Erythrocytes were washed twice in physio- 
logical saline and were resuspended in fresh saline at appropriate concentrations. 
Preparation of Hemolysate Supernatant.--2 ml of packed erytbroeytes  were subjected to 
hypotonic lysis with 6 ml of glass-distilled, demineralized H~O, the suspension was  centri- 
fuged at 1000 g for 10 rain to remove leukocytes, and the supernatant centrifuged at 34,000 g 
for a minimum of 200 min at 4°C. The supernatant obtained from this centfifugation was 
readjusted  to 0.9% salinity with sodium chloride and filter sterilized through 0.2 or 0.45 /z 
Millipore filteIs under pressure. Material was normally used within 1 wk of preparation. In 
later experiments the filtrate was furthei passed through 50 m# pore filters ~ithout apparent 
loss of activity.  In addition, prolonged storage at --20°C did not adversely affect the prep- 
aration. 
Assay for Immune Response.--Plaque assays were performed by use of the liquid mono- 
layer assay of Cunningham and Szenberg (14). Indirect plaque assays were carried out by 
addition of 0.025 ml of rabbit anti-mouse gamma globulin (Difco Laboratories, Inc., Detroit, 
Mich.), 1/50 dilution, using duplicate test material. Adjustment for quenching of 19S plaques 
proved unnecessary because of the low level of 19S plaques. Agglutination tests were carried 
out on serial twofold dilutions of serum prepared from blood obtained from the retro-orbital 
sinus. 
Cell Counts.--Cell counts were obtained either by use of a hemacytometer or with a Nu- 
clear Chicago Particle Size Analyzer (Nuclear-Chicago, Des Plaines, Ill.)  (Coulter principle) 
appropriately corrected for dead time and coincidence. 
RESULTS 
Tolerizing  Ability of SRBC Hemolysate Supernatant (SHS).--Adult BALB/C 
mice were given daily intravenous injections of 0.2 ml of SHS for 7 days; they 
were  challenged with  an immunizing dose  of  2.5  )<  l0  s SRBC  on day 8  and 
assayed 4 days later. The results, shown in Table I  (group A) indicate that this 
treatment reduces the response to  25%  of normal. Paral]el experiments indi- 
cated, moreover, that the reduction was specific, since this treatment did not 
reduce the ability of animals to respond to horse red blood cells. 
An attempt  was  made  to  render animals more  completely tolerant by in- 
creased number of injections (Table I, group B)  or by increasing the dose of a 
single injection (Tab]e I, group C and other experiments) but no further increase 
in the amount of suppression was obtained. To examine the length of time that 
SHS  treatment could suppress the  immune response to  SRBC,  animals were 
tested  at  varying times after  completion of  treatment. The results  (Table I, 
group D) indicate that tolerance remained stable for at least 1 month. 
In order to faci]itate experimentation we next examined the effects of intra- 
peritoneal injections of SHS. We found that seven daily injections of 0.4 ml of 
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TABLE  I 
Spleen PFC Response of AdMt  BALB/C Mice Injecled Inh'avenously wilh Sheep Red  Blood 
Cell Itemolysale Supernatant (SHS)* 
Group 
Experimental  Control 
Treatment  No. of  Average PFC/10~  No. of  Average PFC/106 
animals  (range)  animals  (range)  Control 
A  7 X  SHS  7  204  6  801  23 
(0.2ml)  1158 300)  (400-1020) 
B  14 M SHS  5  250  5  1100  22 
(0.2ml)  (220 310)  (1050 1200) 
C  7 X  SHS 
0.05ml  3  273  26 
(260-330) 
3  176  17 
1160 260)  4  1055 
3  270  (860-1360)  25 
(150-330) 
3  224  21 
(200-260) 
0.1ml 
0.2 ml 
0.3 ml 
7XSIIS (challenged  after) 
I  day  5 
8 days  5 
16 days  5 
32  days  5 
* cf. reference 15. 
190  3  1030  18 
(150-220)  (750-1500) 
210  3  1003  22 
{180-240)  1890-1070) 
238  3  1137  2I 
(190-270)  11050-1210) 
175  3  963  18 
(I00-238)  (865 1002) 
SRBC as were intravenous injections. Moreover, five daily injections were ade- 
quate; with four injections, however, significant but not maximal reduction in 
responsiveness was observed. 
Because of the more ready availability of BDF1 mice we tested the effect of 
SHS on such animals. We found that BDF1 mice responded at least as well to 
the tolerizing effect of SHS  as did BALB/C  mice (Table II).  For most subse- 
quent experiments,  therefore, we adopted the procedure of treating BDF1  ani- 
mals with five intraperitoneal injections of 0.4 ml of SHS, followed after a few 
days by challenge with 5  X  10 8 intact SRBC,  and assayed for plaque-forming 
cells (PFC) 4  days after challenge. 
Specificily  of Induced  Unresponsiveness.--To  examine  more  critically  the 
question of specificity  of tolerization, reciprocal  experiments were carried  out 
using horse red blood cell hemolysate supernatant (HHS)  as well as SHS. Ani- 
mals were treated either with SHS, with HHS,  or with both preparations, and 
subsequently challenged with either HRBC or SRBC. The results are shown in 
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TABLE  II 
F_:ffects of Graded Doses  or  Varied Numbers of Intraperitoneal Injections of Sheep  Erythrocyte 
Hemolysate Supernatant (SHS) on Response of BDF1 Mice to SRBC 
Treatment  No.  of animals  PFC/spleen  X  10-4 -4- sE  (range)  Control  PFC/10~ 
ml  % 
-SRBC  8  0.2  (0-0.5)  0  0.1 
+SRBC  8  106.9  4-  11(72-155)  100  34.8 
1  X  SHS  0.4  8  73.8  4-  20(23-201)  69  30.1 
2  X  "  0.4  8  44.6  4-  13(17-123)  42  18.3 
3  X  "  0.4  8  32.0  4-  7(12-68)  30  20.2 
4  X  "  0.4  8  18.8  ±  4(8-43)  18  8.3 
5  X  "  0.4  8  8.2  4.  7(1-18)  8  4.0 
5  X  "  0.2  8  27.4  4.  8(11-80)  26  12.6 
5  X  "  0.i  8  40.8  -4-  6(6-60)  38  24.4 
5  X  "  0.05  8  76.0  4-  15(38-170)  71  26.3 
TABLE  III 
Spec{Ncity  of Tolerization with Erythrocyte Hemolysate Supernatant 
Treatment 
SRBC  challenge  HRBC  challenge 
SRBC assay  HRBC  assay  SRBC  assay  HRBC  assay 
PF6/spleen × 10  -4. 
None  47.6  0.4  5.2  27.2 
SHS  2.8  0.2  0.2  36.5 
HHS  45.7  1.4  1.3  7.6 
SHS  +  HHS  1.4  0.3  0.3  0.3 
* Four animals per group. 
as SHS influenced only the reaction against SRBC. Treatment with both SHS 
and HHS impaired the response to both antigens. 
Immunogenicity of SHS.Ipreparations of SHS  were  routinely checked for 
antigenicity by injecting 0.4 ml of the material into adult mice and examining 
spleens  from these animals for PFC 4 days after injection. On occasion a prep- 
aration was found to be mildly antigenic, presumably due to contaminant ma- 
terial.  Such a  preparation was excluded from further use.  Most preparations 
were not antigenic by this test. 
We next  examined  the  possibility  that  SHS  might  prove immunogenic at 
doses other than those used in our tolerance experiments. We therefore injected 
SHS in amounts ranging from 0.001 to 0.8 ml intraperitoneally into test animals 
whose spleens  were subsequently examined for PFC. In no instance were  the 
number of PFC in excess of background; indeed the data were suggestive of a 
decrease in PFC, but this point was not pursued to reach a level of significance. 
To ascertain that the route of injection was not critical, 0.1-0.4 ml of SHS 
was injected via the lateral  tail vein and spleens  were subsequently examined 1670  ANDERSON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
for both direct  (19S)  and indirect  (7S)  PFC. Again there was no indication of 
immunogenicity. 
To determine if SHS  could become immunogenic when administered in  ad- 
juvant, two groups of six animals were injected with 0.2 ml of a  1 : 1 mixture of 
Freund's complete adjuvant with either HSH (experimental) or saline (control). 
The spleens of both groups assayed after 4 days did not differ significantly from 
each  other  in  the  number of PFC,  although  the  number  of observed  "back- 
ground" plaques in both groups rose to an average of 15(10 PFC/spleen in con- 
trast to uninjected animals which routinely give background levels of 300  500 
PFC/spleen.  Cells of the mesenteric and inguinal  lymph nodes also showed no 
response to SHS in adjuvant. 
DISCUSSION 
Our experiments show that animals can be made substantially less responsive 
to heterologous erythrocytes by a  nonimmunogenic red  blood cell  hemolysate 
supernatant  fraction, without the addition of lympholytic or cytotoxic agents. 
It appears to us that this presents us with  a  situation  analogous to that first 
described by Dresser (16)  for protein antigens, and which has been so valuable 
in analysis of questions  of immunological unresponsiveness  (cf. reference 10). 
Clearly, further characterization of the tolerogenic supernatants is required, and 
initial  attempts at purification of our material are encouraging. 
We feel that tolerance produced by fractions obtained from hemolyzed eryth- 
rocytes are more likely to  approximate naturally  occurring  tolerance  than  is 
tolerance produced with the aid of cytotoxic drugs. For example, immunoincom- 
petent animals such as the neonatal mouse do clear SRBC from the circulation. 
Nonimmunological  clearance  could  well  lead  to  the  production  of  tolerogens 
which might effectively diminish the subsequent response to SRBC. Moreover, 
if one considers the heterologous erythrocyte as a cell rather than as an antigen 
one can readily envision a chronology" of development that, by' this mechanism, 
leads to restriction of humoral responses directed against cellular self-antigens. 
SUMMARY 
Adult mice injected with a sheep red blood cell hemolysate supernatant frac- 
tion were found  to have a  severelv reduced  responsiveness to subsequent  im- 
munization with sheep red blood cells. The induced unresponsiveness was found 
to be specific,  as  tested  by reciprocal experiments involving  horse and  sheep 
erythrocyte preparations.  The  tolerogenic material  did  not  appear  to  be im- 
munogenic. 
The technical  assistance of Phyllis Halloran and  Louis Kubai in portions of this study is 
gratefully acknowledged. 
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